The ‘Exotic’ Systemic Parasitoses: Limited Geographical Distribution; Rarely Encountered in the UK

  • G. C. Cook
Part of the The Bloomsbury Series in Clinical Science book series (BLOOMSBURY)


The majority of the protozoan and helminthic infections which have been covered in the previous chapters are either indigenous to the United Kingdom, or are introduced (not infrequently) by travellers and members of the minor ethnic groups (often after visits to their relations in Africa, Asia or the Caribbean). In this chapter the emphasis is on two groups of protozoan infections — trypanosomiasis and leishmaniasis — and a helminthic one — filariasis. These are rarely encountered in the UK and when they are, they are usually referred to one of the specialist centres; therefore the average physican has little or no experience of their diagnosis and chemotherapy. As with so many of the infections outlined in this monograph, serological diagnosis has improved remarkably during the last decade or so. However, chemotherapy has lagged behind that which is now available for many of the other parasitoses; older, toxic preparations are still widely in use (Cook 1988). The reason(s) for this is that little or no financial reward results from the development of chemotherapeutic agents for these diseases, which are localized geographically to tropical countries — mostly in Africa or India. In consequence the pharmaceutical industry tends not to invest in research in this neglected area (Garattini 1988; Scott 1988). Despite this, there have been some advances and these have been reviewed recently (Cook 1990).


Visceral Leishmaniasis Adult Worm Cutaneous Leishmaniasis Meglumine Antimoniate American Cutaneous Leishmaniasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Apt W, Arribada A, Arab F, Ugarte JM, Luksic I, Solé C (1986) Clinical trial of benznidazole and an immunopotentiator against Chagas’ disease in Chile. Trans R Soc Trop Med Hyg 80: 1010PubMedCrossRefGoogle Scholar
  2. Ballou WR, McClain JB, Gordon DM, Shanks GD, Andujar J, Berman JD, Chulay JD (1987) Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis. Lancet 2: 13–16PubMedCrossRefGoogle Scholar
  3. Barioglio SR de, Lacuara JL, Oliva PP de (1987) Effects of clomipramine upon motility of Trypanosoma cruzi. J Parisitol 73: 451–452CrossRefGoogle Scholar
  4. Beaver PC (1989) Intraocular filariasis: a brief review. Am J Trop Med Hyg 40: 40–45PubMedGoogle Scholar
  5. Belazzoug S, Neal RA (1986) Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria. Trans R Soc Trop Med Hyg 80: 670–671PubMedCrossRefGoogle Scholar
  6. Bittencourt AL (1976) Congenital Chagas’ disease. Am J Dis Child 130: 97–103PubMedGoogle Scholar
  7. Borelli D (1987) A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev Infect Dis 9: S57–S63PubMedCrossRefGoogle Scholar
  8. Brandao HJS, Zulian R (1966) Nerve cell depopulation in chronic Chagas’ disease in a qualitative study in the cerebellum. Rev Inst Med Trop Säo Paulo 8: 281–286PubMedGoogle Scholar
  9. Breniére SF, Carrasco R, Antezana G, Desjeux P, Tibayrenc M (1989) Association between Trypanosoma cruzi zymodemes and specific humoral depression in chronic chagasic patients. Trans R Soc Trop Med Hyg 83: 517CrossRefGoogle Scholar
  10. Brown WJ, Voge M (1982) Neuropathology of parasitic of parasitic infections. Oxford University Press, Oxford, p 240Google Scholar
  11. Bruce D (1895) Preliminary report on the tsetse fly disease or nagana, in Zululand. Bennett and Davis, DurbanGoogle Scholar
  12. Burchard GD, Kern P (1987) Failure of high dose mebendazole as a microfilaricide in patients with loaiasis. Trans R Soc Trop Med Hyg 81: 420PubMedCrossRefGoogle Scholar
  13. Castellani A (1903) On the discovery of a species of trypanosoma in the cerebrospinal fluid of cases of sleeping sickness. Proc R Soc 71: 501–508CrossRefGoogle Scholar
  14. Chagas C (1909) Nová trypanozomiaze humana. Estudos sobre a morfolojia e o cielo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ájente etiolojico de nova entidade mórbida do nomen. Mem Inst Osw Cruz 1: 159–218CrossRefGoogle Scholar
  15. Chulay JD (1984) Cutaneous leishmaniasis of the new world. In: Strickland GT (ed) Hunter’s tropical medicine, 6th edn. Saunders, Philadelphia, pp 589–593Google Scholar
  16. Chulay JD, Manson-Bahr PEC (1984a) Visceral leishmaniasis (Kala-azar). In: Strickland GT (ed) Hunter’s tropical medicine, 6th edn. Saunders, Philadelphia, pp 578–585Google Scholar
  17. Chulay JD, Manson-Bahr PEC (1984b) Cutaneous leishmaniasis of the old world. In: Strickland GT (ed) Hunter’s tropical medicine, 6th edn. Saunders, Philadelphia, pp 585–589Google Scholar
  18. Connor DH, Gibson DW, Taylor HR, Mackenzie CD, Meyers WM, Neafie RC (1984) Onchocerciasis. In: Strickland GT (ed) Hunter’s tropical medicine, 6th edn. Saunders, Philadelphia, pp 667–680Google Scholar
  19. Cook GC (1988) Chemotherapy of parasitic infections. Curr Opin Infect Dis 1:423–1. 438Google Scholar
  20. Cook GC (1990) ‘Exotic’ parasitic infections: recent progress in diagnosis and management. J Infect 20:95–102Google Scholar
  21. Cunningham DD (1885) On the presence of peculiar parasitic organisms in the tissue of a specimen of Delhi boil. Sci Mem Med Off Army India 1: 21–31Google Scholar
  22. Dennis DT (1984) Bancroftian filariasis. In: Strickland GT (ed) Hunter’s tropical medicine, 6th edn. Saunders, Philadelphia, pp 649–659Google Scholar
  23. Diallo S, Aziz MA, Lariviere M, Diallo JS, Diop-Mar I, N’Dir O, Badiane S, Py D, Schulz-Key H, Gaxotte P, Victorius A (1986) A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis. Trans R Soc Trop Med Hyg 80: 927–934PubMedCrossRefGoogle Scholar
  24. Donovan C (1903) On the possibility of the occurrence of trypanosomiasis in India: Br Med J 2: 79Google Scholar
  25. Duggan AJ, Hutchinson MP (1966) Sleeping sickness in Europeans: a review of 109 cases. J Trop Med Hyg 69: 124–131PubMedGoogle Scholar
  26. Dunn RS (1972) Sugar and slaves: the rise of the planter class in the English West Indies, 1624–1713. University of North Carolina Press, Williamsburg, VA, p 359Google Scholar
  27. Dutton JE (1902) Preliminary note upon a trypanosome occurring in the blood of man. Thompson Yates Lab Rep 4: 455–468Google Scholar
  28. El-On J, Messer G (1986) Leishmania major: antileishmanial activity of methylbenzethonium chloride. Am J Trop Med Hyg 35: 1110–1116Google Scholar
  29. El-On J, Livshin R, Evan-Paz Z, Hamburger D, Weinrauch L (1986a) Topical treatment of cutaneous leishmaniasis. J Invest Dermatol 87: 284–288PubMedCrossRefGoogle Scholar
  30. El-On J, Rubinstein N, Kernbaum S, Schnur LF (1986b) In vitro and in vivo anti-leishmanial activity of chlorpromazine alone and combined with N-meglumine antimonate. Ann Trop Med Parasitol 80:509–517Google Scholar
  31. Garattini S (1988) Remedies for tropical diseases. Lancet 1: 1338PubMedCrossRefGoogle Scholar
  32. Goldsmith RS (1988) Recent advances in the treatment of helminthic infections: ivermectin, albendazole and praziquantel. In: Leech JH, Sande MA, Root RK (eds) Parasitic infections. Churchill Livingstone, New York and Edinburgh, pp 327–347Google Scholar
  33. Harms G, Zwingenberger K, Chehade AK, Talhari S, Racz P, Mouakeh A, Douba M, Näkel L, Naiff RD, Kremsner PG, Feldmeier H, Bienzle U (1989) Effects of intradermal gamma-interferon in cutaneous leishmaniasis. Lancet 1: 1287–1292PubMedCrossRefGoogle Scholar
  34. Hayes MM, Cox HW (1984) Complement reversal of immunosuppression induced with plasma of rats infected with Trypanosoma brucei rhodesiense. J Parasitol 70: 864–870PubMedCrossRefGoogle Scholar
  35. Hoff R, Teixeira RS, Carvalho JS, Mott KE (1978) Trypanosoma cruzi in the cerebrospinal fluid during the acute stage of Chagas’ disease. New Engl J Med 298: 604–606Google Scholar
  36. Hopkins DR (1988) Dracunculiasis eradication: the tide has turned. Lancet 2: 148–150PubMedCrossRefGoogle Scholar
  37. Hudson KM, Terry RJ (1979) Immunodepression and the course of infection of a chronic Trypanosoma brucei infection in mice. Parasite Immunol 1: 317–326PubMedCrossRefGoogle Scholar
  38. Jayaraman KS (1988) Leishmaniasis resurgent in India. Nature 333: 590Google Scholar
  39. Jennings FW (1987) Chemotherapy of late-stage trypanosomiasis: the effect of the nitrothiazole compounds. Trans R Soc Trop Med Hyg 81: 616PubMedCrossRefGoogle Scholar
  40. Kinmond S, Galea P, Simpson EM, Parida SK, Goel KM (1989) Kala-azar in a Scottish child. Lancet 2: 325PubMedCrossRefGoogle Scholar
  41. Köberle F (1974) Pathogenesis of Chagas’ disease. In: Trypanosomiasis and leishmaniasis with special reference to Chagas’ disease. Associated Scientific Publishers, Amsterdam, pp 137–152. (Ciba Foundation symposium 20)Google Scholar
  42. Kohn LA (1983) Charles Darwin’s chronic ill health. Bull Hist Med 37: 239–256Google Scholar
  43. Laukamm-Josten U (1987) The paralyzing effect of midazolam on Onchocerca volvulus microfilariae in vitro. Am J Trop Med Hyg 37: 152–156PubMedGoogle Scholar
  44. Leech JH, Sande MA, Root RK (eds) (1988) Parasitic infections. Churchill Livingstone, New York and Edinburgh, p 364Google Scholar
  45. Leishman WB (1903) On the possibility of the occurrence of trypanosomiasis in India. Br Med J 1: 1252–1254 and 2: 1376–1377CrossRefGoogle Scholar
  46. Manson P (1877) Filaria sanguinis hominis. Med Rep Imperial Customs, China, 13th issue: 30–38Google Scholar
  47. Manson-Bahr PEC, Bell DR (eds) (1987a) African trypanosomiasis. In: Manson’s tropical diseases, 19th edn. Bailliere Tindall, London, pp 54–73Google Scholar
  48. Manson-Bahr PEC, Bell DR (eds) (1987b) American trypanosomiasis (Chagas’ disease). In: Manson’s tropical diseases, 19th edn. Bailliere Tindall, London, pp 74–86Google Scholar
  49. Manson-Bahr PEC, Bell DR (eds) (1987c) Filariasis. In: Manson’s tropical diseases, 19th edn. Bailliere Tindall, pp 353–406Google Scholar
  50. Mar JJ, Docampo R (1986) Chemotherapy for Chagas’ disease: a perspective of current therapy and considerations for future research. Rev Infect Dis 8: 884–903CrossRefGoogle Scholar
  51. Marsden PD (1984) American trypanosomiasis. In: Strickland GT (ed) Hunter’s tropical medicine, 6th edn. Saunders, Philadelphia, pp 565–573Google Scholar
  52. Marsden PD (1989) American trypanosomiasis. Br Med J 299: 969–970CrossRefGoogle Scholar
  53. McCann PP, Bitonti AJ, Bacchi CJ, Clarkson AB (1987) Use of difluoromethylornithine ( DFMO, eflornithine) for late-stage African trypanosomiasis. Trans R Soc Trop Med Hyg 81: 701Google Scholar
  54. Medawar PB (1964) Darwin’s illness. Ann Intern Med 61: 782–787PubMedGoogle Scholar
  55. Molyneux DH, Raadt P de, Seed JR (1984) African human trypanosomiasis. In: Gilles HM (ed) Recent advances in tropical medicine 1. Churchill Livingstone, Edinburgh, London, pp 39–62Google Scholar
  56. Muller R (1971) Dracunculus and dracontiasis. Adv Parasitol 9: 73PubMedCrossRefGoogle Scholar
  57. Muller R (1984) Dracontiasis. In: Strickland GT (ed) Hunter’s tropical medicine, 6th edn. Saunders, Philadelphia, pp 687–689Google Scholar
  58. Nanduri J, Kazura JW (1989) Clinical and laboratory aspects of filariasis Clin Microbiol Rev 2: 39–50Google Scholar
  59. Nantulya VM, Musoke AJ, Rurangirwa FR, Barbet AF, Ngaira JM, Katende JM (1982) Immune depression in African trypanosomiasis: the role of antigenic competition. Clin Exp Immunol 47: 234–242PubMedGoogle Scholar
  60. Neva FA (1988) Recent advances in the diagnosis and management of leishmaniasis and American trypanosomiasis. In: Leech JH, Sande MA, Root RK (eds) (1988) Parasitic infections. Churchill Livingstone, New York and Edinburgh, pp 243–258Google Scholar
  61. Nutman TB, Reese W, Poindexter RW, Ottesen EA (1988) Immunologic correlates of the hyperresponsive syndrome of loiasis. J Infect Dis 157: 544–550PubMedCrossRefGoogle Scholar
  62. Oka M, Ito Y, Furuya M, Osaki H (1984) Trypanosoma gambiense: immunosuppression and polyclonal-cell activation in mice. Exp Parasitol 58: 209–214Google Scholar
  63. Okamura M, Correa Netto A (1963) Etiopatogenia do megacolo Chagasico. Rev Hosp Clin Fac Med Univ Sao Paulo 18: 351–360Google Scholar
  64. Osuna A, Ruiz-Perez LM, Lopez MC, Castanys S, Gamarow F, Craciunescu DG, Alonso C (1987) Antitrypanosomal action of cis-diamminedichloroplatinum ( II) analogs. J Parasitol 73: 272–277Google Scholar
  65. Pehrson P-O, Wahlgren M, Bengtsson E (1982) Intracranial calcifications probably due to congenital Chagas’ disease. Am J Trop Med Hyg 31: 449–451PubMedGoogle Scholar
  66. Pepin J, Milord F, Guern C, Mpia B, Ethier L, Mansinsa D (1989a) Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in Gambiense sleeping sickness. Lancet 1: 1246–1250PubMedCrossRefGoogle Scholar
  67. Pepin J, Milord F, Mpia B, Meurice F, Ethier L, De Groof D, Bruneel H (1989b) An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire. Trans R Soc Trop Med Hyg 83: 514–517PubMedCrossRefGoogle Scholar
  68. Peters W, Killick-Kendrick R (eds) (1987) The leishmaniases in biology and medicine, 2 vols. Academic Press, London, p 941Google Scholar
  69. Price EW (1989) Mappa Mundi and tropical medicine. Trans R Soc Trop Med Hyg 83: 574PubMedCrossRefGoogle Scholar
  70. Raseroka BH, Ormerod WE (1985) Protection of the sleeping sickness trypanosome from chemotherapy by different parts of the brain. E Afr Med J 62: 452–458Google Scholar
  71. Raseroka BH, Ormerod WE (1986) The trypanocidal effect of drugs in different parts of the brain. Trans R Soc Trop Med Hyg 80: 634–641PubMedCrossRefGoogle Scholar
  72. Richard-Lenoble D, Kombila M, Rupp EA, Pappayliou ES, Gaxotte P, Nguiri C, Aziz MA (1988). Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections. Am J Trop Med Hyg 39: 480–483PubMedGoogle Scholar
  73. Robertson M (1913) Notes on the life history of Trypanosoma gambiense. Repts Sleep Sickn Comm R Soc 13: 119Google Scholar
  74. Rothova A, Lelij A van der, Stilma JS, Wilson WR, Barbe RF (1989) Side-effects of ivermectin in treatment of onchocerciasis. Lancet 1: 1439–1441PubMedCrossRefGoogle Scholar
  75. Schmidt H, Bafort JM (1985) African trypanosomiasis: treatment-induced invasion of brain and encephalitis. Am J Trop Med Hyg 34: 64–68PubMedGoogle Scholar
  76. Scott EMD (1988) Remedies for tropical diseases. Lancet 2: 108PubMedCrossRefGoogle Scholar
  77. Singh MP, Mishra M, Khan AB, Ramdas SL, Panjiyar S (1989) Gold treatment for Kala-azar. Br Med J 299: 1318CrossRefGoogle Scholar
  78. Spencer HC (1984) African trypanosomiasis. In: Strickland GT (ed) Hunter’s tropical medicine, 6th edn. Saunders, Philadelphia, pp 553–565Google Scholar
  79. Spry CJF (1988) Eosinophils: a comprehensive review and guide to the scientific and medical literature. Oxford University Press, Oxford, p 450Google Scholar
  80. Stephens JWW, Fantham HB (1910) On the peculiar morphology of a trypanosome from a case of sleeping sickness and the possibility of its being a new species (T. rhodesiensè). Proc R Soc Lond (Biol) 83: 28–33CrossRefGoogle Scholar
  81. Sypek JP, Wyler DJ (1988) Host defense in leishmaniasis. In: Leech JH, Sande MA, Root RK (eds) Parasitic infections. Churchill Livingstone, New York and Edinburgh, pp 221–242Google Scholar
  82. Tamashiro WK, Ibrahim MS, Moraga DA, Scott AL (1989) Dirofilaria immitis: studies on anti-microfilarial immunity in Lewis rats. Am J Trop Med Hyg 40: 368–376Google Scholar
  83. Taylor HR, Semba RD, Newland HS, Keyvan-Larijani E, White A, Dukuly Z, Greene BM (1989) Ivermectin treatment of patients with severe ocular onchocerciasis. Am J Trop Med Hyg 40: 494–500PubMedGoogle Scholar
  84. Thakur CP, Kumar M, Kumar P, Mishra BN, Pandey AK (1988) Rationalisation of regimens of treatment of Kala-azar with sodium stibogluconate in India: a randomised study. Br Med J 296: 1557–1561CrossRefGoogle Scholar
  85. Traub N, Hira PR, Chinta C, Mhango C (1978) Congenital trypanosomiasis: report of a case due to Trypanosoma brucei rhodesiense. E Afr Med J 55: 477–481Google Scholar
  86. Turner M (1980) How trypanosomes change coats. Nature 284: 13PubMedCrossRefGoogle Scholar
  87. Weinberg JR, Wright PA, Cook GC (1989) Tropical pyomyositis associated with Trypanosoma brucei rhodesiense infection in a Europid. Trans R Soc Trop Med Hyg 83: 77–79PubMedCrossRefGoogle Scholar
  88. Willmott S (ed) (1980) The eosinophil in tropical disease. Trans R Soc Trop Med Hyg 74[Suppl]:l–63Google Scholar

Copyright information

© Springer-Verlag London Limited 1990

Authors and Affiliations

  • G. C. Cook
    • 1
    • 2
    • 3
    • 4
    • 5
  1. 1.Hospital for Tropical DiseasesUniversity College HospitalUK
  2. 2.St Luke’s Hospital for the ClergyUK
  3. 3.London School of Hygiene and Tropical MedicineUK
  4. 4.Royal Nigerian ArmyNigeria
  5. 5.Makerere UniversityUganda

Personalised recommendations